Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

135
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
135
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

269
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
269
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

192
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
192
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.8K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K
Antibiotic Selection00:57

Antibiotic Selection

55.0K
Overview
55.0K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

173
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
173

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Study of Frequency and Secular Trends of Seropositivity for Cysticercosis in Peru Over 20 Years.

Tropical medicine & international health : TM & IH·2026
Same author

[Recommendations for the management of menopausal vasomotor symptoms in clinical practice].

Semergen·2025
Same author

Analysis of standard aerobic bacterial culture and sensitivity results from three laboratories for canine pyoderma.

The Journal of small animal practice·2025
Same author

Hyperbaric oxygen therapy enables pain reduction and healing in painful chronic wounds, including in calciphylaxis.

Annales de dermatologie et de venereologie·2024
Same author

[Patients hospitalized in the ICU for acute coronary syndrome from 2012 to 2021: A single-center retrospective study].

Annales de cardiologie et d'angeiologie·2024
Same author

Is there a role for intestinal sporobiota in the antimicrobial resistance crisis?

Microbiological research·2024

Related Experiment Video

Updated: Aug 26, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K

Emerging alternatives against Clostridioides difficile infection.

A Romero-Rodríguez1, C Martínez de la Peña2, S Troncoso-Cotal3

  • 1Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas Universidad Nacional Autónoma de México, Ciudad de México, 04510, Mexico.

Anaerobe
|October 10, 2022
PubMed
Summary
This summary is machine-generated.

Clostridioides difficile infection (CDI) poses a global health threat, with rising cases and antibiotic resistance. This review explores novel alternatives to combat CDI, addressing challenges like recurrence and drug resistance.

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.0K

Related Experiment Videos

Last Updated: Aug 26, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.0K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Clostridioides difficile infection (CDI) is a leading cause of infectious diarrhea globally.
  • Increasing morbidity and mortality underscore the urgent need for effective CDI management.
  • Current antibiotic treatments face challenges of high recurrence rates and antimicrobial resistance.

Purpose of the Study:

  • To review emerging alternatives for Clostridioides difficile infection (CDI) treatment.
  • To analyze how novel strategies can overcome limitations of current CDI therapies.
  • To discuss the advantages and challenges of both established and experimental CDI interventions.

Main Methods:

  • Literature review of current and experimental Clostridioides difficile infection (CDI) treatments.
  • Analysis of therapeutic strategies focusing on recurrence, spore resistance, and drug resistance.
  • Comparative assessment of antibiotic therapies versus novel alternatives.

Main Results:

  • Antibiotics remain standard but are linked to CDI relapse and resistance.
  • Emerging alternatives show promise in mitigating CDI challenges.
  • Significant hurdles remain in developing and implementing new CDI treatment options.

Conclusions:

  • Novel therapeutic strategies are crucial to address the growing challenges of Clostridioides difficile infection (CDI).
  • A comprehensive approach evaluating both current and experimental options is necessary for effective CDI control.
  • Further research and development are essential to combat CDI recurrence and antimicrobial resistance.